BioCentury | Sep 3, 2015
Translation in Brief
The Thetis thesis
...Thetis Pharmaceuticals LLC believes it can improve upon the diabetes drug metformin with TP-113 , a...
...would be cost-prohibitive, he said. Sciavolino told BioCentury that the company generated IP by creating TP-113...
...would be cost-prohibitive, he said. Sciavolino told BioCentury that the company generated IP by creating TP-113...
